Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
Using AUA Guidelines
Access to AUA guidelines is provided free for individuals’ clinical use only. Anyone accessing AUA guidelines for any other purpose must obtain a license in advance. Licenses for academic, research and educational purposes can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to, and limited authorized use of AUA guidelines is a member benefit. Members are granted a limited license to access and use the AUA Guidelines for their individual, non-commercial use, for clinical, academic, educational, and research purposes, in accordance with the AUA Guidelines Terms and Conditions of Use. Members who wish to use the Guidelines for any other purpose, or in any manner not authorized by this limited license grant or by the AUA Guidelines Terms and Conditions of Use must request and obtain a license/permission in advance. Licenses for business or institutional academic, research and educational related purposes (e.g., use in course packs or for employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for individual clinical use only, in accordance with the AUA Guidelines Terms and Conditions of Use. Anyone accessing AUA guidelines for any other purpose must obtain a license/permission in advance. Licenses for academic, research and educational purposes (e.g., in course packs or employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for health care providers for their individual clinical use only. Patients and the general public are provided a summary of the guidelines. Patients who wish to discuss the full guidelines should consult with their healthcare provider.
Guideline Resources
Unabridged PDF for this Guideline
The Journal of Urology® Articles
Endorsed by The International Society for the Study of Women’s Sexual Health (ISSWSH), The Sexual Medicine Society of North America (SMSNA), and The Menopause Society (TMS).
Purpose
This Guideline covers the evaluation and treatment of women who present to a clinician with symptoms and signs of genitourinary syndrome of menopause (GSM). GSM describes the spectrum of symptoms and physical changes resulting from declining estrogen and androgen concentrations in the genitourinary tract during perimenopause and after menopause. This Guideline endeavors to provide clinicians with information regarding identification, diagnosis, counseling and treatment for patients with GSM to optimize symptom control and improve quality of life while minimizing adverse effects. The strategies defined in this document were derived from evidence-based and consensus-based processes.
Key Takeaways
This Guideline acknowledges the importance of shared decision-making (SDM) as the optimal strategy to individualize patient care. This document will guide all types of clinicians who evaluate, manage, and treat patients with GSM across a multitude of disciplines and serves as a valuable reference for effective evidence-based care in relation to GSM. Topics covered include the following:
- Screening, evaluation, and physical exam of patients who present with GSM symptoms and signs
- Hormonal and non-hormonal treatment options, including local, low-dose vaginal estrogen
- Proper surveillance of GSM patients who undergo hormonal-based treatment
- Follow-up of all GSM patients who undergo any kind of therapy to alleviate symptoms
Create a free account to access expanded content and resources.
AUA Clinical Practice Guidelines are developed by multidisciplinary panels of experts based on rigorous systematic review of current urologic research.
Consultants
Systematic Review prepared by the Minnesota Evidence-based Practice Center, Minneapolis, MN. Investigators: Elisheva R. Danan, MD, MPH; Susan Diem, MD, MPH; Catherine Sowerby, BA; Kristen Ullman, MPH; Kristine Ensrud, MD, MPH; Adrienne Landsteiner, PhD, MPH; Nancy Greer, PhD; Nicholas Zerzan, MPH; Maylen Anthony, MPH; Caleb Kalinowski, MS; Mary Forte, PhD, DC; Hamdi I. Abdi, MPH; Jessica K. Friedman, PhD; Rahel Nardos, MD, MS; Cynthia Fok, MD, MPH; Philipp Dahm, MD, MHSc; Mary Butler, PhD, MBA; Timothy J. Wilt, MD, MPH
TOOLS & RESOURCES

- AUAUniversity Podcast: Genitourinary Syndrome of Menopause
- AUAUniversity Podcast: Recurrent Uncomplicated Urinary Tract Infections in Women
- Update Series (2026) Lesson 21: Genitourinary Syndrome of Menopause: A Clinical Review of the Guidelines and Case Illustrations (Subscribers Only)
- AUANews Inside Tract Podcast: Transforming GSM Care: How Evidence, Experts, and Advocacy Changed the Label
- Patient Education Materials: Genitourinary Syndrome of Menopause